tiprankstipranks
Advertisement
Advertisement

DE:B72 Stock Latest News

ATAI Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Pre-EarningsATAI Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2d ago
ATAI
Psychedelic: AtaiBeckley reports publication of BPL-003 study results
PremiumThe Fly
Psychedelic: AtaiBeckley reports publication of BPL-003 study results
6d ago
ATAI
CMND
AtaiBeckley: Advancing BPL-003 Into Pivotal Phase 3 With Strategic Optionality and Strong Cash Runway Supporting a Buy Rating
PremiumRatings
AtaiBeckley: Advancing BPL-003 Into Pivotal Phase 3 With Strategic Optionality and Strong Cash Runway Supporting a Buy Rating
7d ago
ATAI
Buy Rating on BPL-003 Underpinned by Strong Phase 2a Efficacy, De-Risked Phase 3 Program, and Upside to $25 Target Price
PremiumRatings
Buy Rating on BPL-003 Underpinned by Strong Phase 2a Efficacy, De-Risked Phase 3 Program, and Upside to $25 Target Price
8d ago
ATAI
Atai Beckley announces publication of Phase 2a BPL-003 study results
PremiumThe Fly
Atai Beckley announces publication of Phase 2a BPL-003 study results
9d ago
ATAI
Psychedelic: Clearmind advances recruitment for CMND-100 trial’s third cohort
PremiumThe FlyPsychedelic: Clearmind advances recruitment for CMND-100 trial’s third cohort
13d ago
ATAI
CMND
Atai Beckley advancing BPL-003 nasal spray towards Phase 3 after FDA meeting
Premium
The Fly
Atai Beckley advancing BPL-003 nasal spray towards Phase 3 after FDA meeting
16d ago
ATAI
ATAI Life Sciences: Reiterating Buy on BPL-003’s Differentiated TRD Profile, Pricing Power, and Long-Dated IP Protection
Premium
Ratings
ATAI Life Sciences: Reiterating Buy on BPL-003’s Differentiated TRD Profile, Pricing Power, and Long-Dated IP Protection
17d ago
ATAI
Atai Beckley reports Q4 EPS ($1.73) vs. (24c) last year
PremiumThe Fly
Atai Beckley reports Q4 EPS ($1.73) vs. (24c) last year
19d ago
ATAI
Atai Beckley sees cash runway into 2029
PremiumThe Fly
Atai Beckley sees cash runway into 2029
19d ago
ATAI
Psychedelic: Helus Pharma reports HLP004 Phase 2 signal detection study results
PremiumThe Fly
Psychedelic: Helus Pharma reports HLP004 Phase 2 signal detection study results
20d ago
PBM
ATAI
AtaiBeckley says aligned with FDA on dual-trial design Phase 3 BPL-003 program
PremiumThe Fly
AtaiBeckley says aligned with FDA on dual-trial design Phase 3 BPL-003 program
22d ago
ATAI
Psychedelic: AtaiBeckley reports EMP-01 met primary objective in Phase 2a trial
PremiumThe FlyPsychedelic: AtaiBeckley reports EMP-01 met primary objective in Phase 2a trial
27d ago
PFE
ABBV
Buy Rating on ATAI Life Sciences Driven by Promising Phase 2a EMP-01 Efficacy and Differentiated Dosing in Social Anxiety Disorder
Premium
Ratings
Buy Rating on ATAI Life Sciences Driven by Promising Phase 2a EMP-01 Efficacy and Differentiated Dosing in Social Anxiety Disorder
27d ago
ATAI
Atai Beckley says EMP-01 met primary safety objectivein Phase 2a trial
Premium
The Fly
Atai Beckley says EMP-01 met primary safety objectivein Phase 2a trial
27d ago
ATAI
Psychedelic: Exclusive talk with nonprofit organization MAPS
PremiumThe Fly
Psychedelic: Exclusive talk with nonprofit organization MAPS
1M ago
ATAI
CMND
Atai Beckley appoints Faerm as Chief Financial Officer
PremiumThe Fly
Atai Beckley appoints Faerm as Chief Financial Officer
1M ago
ATAI
Psychedelic: Analyst initiates Atai Beckley with Buy rating
PremiumThe Fly
Psychedelic: Analyst initiates Atai Beckley with Buy rating
2M ago
PBM
ATAI
Atai Beckley initiated with a Buy at Guggenheim
PremiumThe Fly
Atai Beckley initiated with a Buy at Guggenheim
2M ago
ATAI
ATAI Life Sciences: Advancing Psychedelic Pipeline Sets Up Data-Rich 2026 and Supports Reiterated Buy Rating
PremiumRatingsATAI Life Sciences: Advancing Psychedelic Pipeline Sets Up Data-Rich 2026 and Supports Reiterated Buy Rating
2M ago
ATAI
Atai Beckley announces presentations at ACNP
Premium
The Fly
Atai Beckley announces presentations at ACNP
2M ago
ATAI
Advancing Neuropsychiatric Pipeline and Clear 2026 Milestones Underpin Buy Rating on ATAI Life Sciences
Premium
Ratings
Advancing Neuropsychiatric Pipeline and Clear 2026 Milestones Underpin Buy Rating on ATAI Life Sciences
3M ago
ATAI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >